Oruka Therapeutics Inc (ORKA)

Oruka Therapeutics Inc. experienced significant insider trading activity recently, with 72 transactions totaling over $40 million in net sales. Executives, including the Chief Medical Officer, offloaded shares through planned divestments following the latest earnings report. Despite a 9.5% decline in stock value over ninety days, the equity remains near its yearly peak.
Ticker: ORKA Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oruka Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.24
Quantity 86,673 -29.2%
Value US$3,458,105
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
248.97
Quantity 65,056 +5.5%
Value US$1,807,857
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
101.11
Quantity 95,281 -0.4%
Value US$425,856
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
101.53
Quantity 1,000 -5.5%
Value US$100,000
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
100.48
Quantity 1,000 -4.1%
Value US$100,000
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
99.52
Quantity 1,000 -6.7%
Value US$100,000
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
107.00
Quantity 1,000 -0.7%
Value US$100,000
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
106.18
Quantity 1,000 -6.3%
Value US$100,000
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
105.28
Quantity 1,000 -30.9%
Value US$100,000
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
104.25
Quantity 1,000 -3.5%
Value US$100,000
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
103.16
Quantity 1,000 -3.4%
Value US$100,000
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
101.98
Quantity 1,000 -2.1%
Value US$100,000
BALL KRISTINE M Non-Executive Director
Transaction date
Planned sale
Price
106.99
Quantity 1,000 -100.0%
Value US$100,000
BALL KRISTINE M Non-Executive Director
Transaction date
Planned sale
Price
106.05
Quantity 1,000 -92.6%
Value US$100,000
BALL KRISTINE M Non-Executive Director
Transaction date
Planned sale
Price
105.31
Quantity 1,000 -79.9%
Value US$100,000
BALL KRISTINE M Non-Executive Director
Transaction date
Planned sale
Price
104.16
Quantity 1,000 -13.2%
Value US$100,000
BALL KRISTINE M Non-Executive Director
Transaction date
Planned sale
Price
103.09
Quantity 1,000 -7.7%
Value US$100,000
BALL KRISTINE M Non-Executive Director
Transaction date
Planned sale
Price
102.10
Quantity 1,000 -6.6%
Value US$100,000
1.4
Arjun Agarwal Officer Officer
Transaction date
Proposed sale
Price
107.17
Quantity 1,000
Value US$100,000
KRISTINE BALL Director Non-Executive Director
Transaction date
Proposed sale
Price
107.17
Quantity 1,000
Value US$100,000
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
98.40
Quantity 1,000 -0.0%
Value US$100,000
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
97.45
Quantity 1,000 -0.1%
Value US$100,000
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
96.70
Quantity 1,000 -0.3%
Value US$100,000
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
95.64
Quantity 1,000 -1.6%
Value US$100,000
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
94.77
Quantity 1,000 -0.7%
Value US$100,000
1.4
LAWRENCE KLEIN Director; Officer Executive Director
Transaction date
Proposed sale
Price
96.87
Quantity 1,000
Value US$100,000
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
79.49
Quantity 3,000 -9.1%
Value US$238,474
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
78.79
Quantity 4,100 -11.1%
Value US$323,037
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
77.21
Quantity 1,000 -2.6%
Value US$77,205
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
76.12
Quantity 500 -1.3%
Value US$38,059
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
74.90
Quantity 400 -1.0%
Value US$29,960
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
77.71
Quantity 200 -0.6%
Value US$15,542
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
76.67
Quantity 700 -2.1%
Value US$53,666
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
75.48
Quantity 1,400 -4.1%
Value US$105,677
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
74.69
Quantity 1,847 -5.1%
Value US$137,957
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
73.89
Quantity 2,853 -7.4%
Value US$210,806
1.3
JOANA GONCALVES Officer Officer
Transaction date
Proposed sale
Price
76.68
Quantity 21,000
Value US$1,610,280
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
82.84
Quantity 200 -1.4%
Value US$16,567
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
81.86
Quantity 1,958 -12.0%
Value US$160,272
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
80.76
Quantity 2,100 -11.4%
Value US$169,596
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
80.03
Quantity 5,741 -23.7%
Value US$459,453
1.4
Arjun Agarwal Officer Officer
Transaction date
Proposed sale
Price
82.11
Quantity 9,999
Value US$821,018
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
84.78
Quantity 200 -0.0%
Value US$16,956
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
84.03
Quantity 8,554 -0.9%
Value US$718,755
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
83.40
Quantity 16,246 -1.7%
Value US$1,354,882
1.4
LAWRENCE KLEIN Director; Officer Executive Director
Transaction date
Proposed sale
Price
83.29
Quantity 25,000
Value US$2,082,250
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
95.75
Quantity 533 -3.6%
Value US$51,035
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
95.31
Quantity 2,667 -8.2%
Value US$254,196
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
94.44
Quantity 601 -1.8%
Value US$56,760
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
93.32
Quantity 3,832 -10.3%
Value US$357,592
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Planned sale
Price
92.37
Quantity 2,900 -7.3%
Value US$267,870
1.4
Arjun Agarwal Officer Officer
Transaction date
Proposed sale
Price
94.96
Quantity 533
Value US$50,614
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Sale
Price
95.71
Quantity 947 -2.9%
Value US$90,637
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
94.22
Quantity 100 -0.3%
Value US$9,422
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
92.99
Quantity 1,366 -4.0%
Value US$127,023
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
92.03
Quantity 3,150 -8.4%
Value US$289,890
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
91.10
Quantity 2,384 -6.0%
Value US$217,173
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Sale
Price
95.71
Quantity 2,452 -0.3%
Value US$234,681
1.4
Quinlan Paul T General Counsel Officer
Transaction date
Sale
Price
95.71
Quantity 1,039 -3.3%
Value US$99,443
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Sale
Price
95.71
Quantity 560 -3.7%
Value US$53,598
1.4
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Sale
Price
95.71
Quantity 906 -0.4%
Value US$86,713
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
94.02
Quantity 200 -1.3%
Value US$18,803
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
93.26
Quantity 2,208 -12.5%
Value US$205,921
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
92.41
Quantity 4,051 -18.6%
Value US$374,367
1.4
Agarwal Arjun Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
91.11
Quantity 3,000 -12.1%
Value US$273,322
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
92.44
Quantity 4,800 -0.5%
Value US$443,691
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
91.90
Quantity 63,596 -6.4%
Value US$5,844,237
1.4
Klein Lawrence Otto Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
90.79
Quantity 6,604 -0.7%
Value US$599,556
1.4
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
92.01
Quantity 4,000 -1.7%
Value US$368,054
1.4
Sandler Laura Lee Chief Operating Officer Officer
Transaction date
Planned sale
Price
91.05
Quantity 1,000 -0.4%
Value US$91,048
1.4
LAURA SANDLER Officer Officer
Transaction date
Proposed sale
Price
92.62
Quantity 5,000
Value US$463,100
1.4
LAWRENCE KLEIN Director; Officer Executive Director
Transaction date
Proposed sale
Price
92.62
Quantity 75,000
Value US$6,946,500
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
112.56
Quantity 2,480 -7.0%
Value US$279,154
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
112.01
Quantity 3,320 -8.6%
Value US$371,886
1.3
Goncalves Joana Chief Medical Officer Officer
Transaction date
Planned sale
Price
110.52
Quantity 300 -0.8%
Value US$33,155
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-16 2026-11-16 PlS Planned sale

Chief Medical Officer

Officer
86,673 -29.2%
18.24
US$3,458,105
86,673 -29.2% 18.24 US$3,458,105
2026-11-16 2026-11-16 PlS Planned sale

Chief Medical Officer

Officer
65,056 +5.5%
248.97
US$1,807,857
65,056 +5.5% 248.97 US$1,807,857
2026-11-16 2026-11-16 PlS Planned sale

Chief Medical Officer

Officer
95,281 -0.4%
101.11
US$425,856
95,281 -0.4% 101.11 US$425,856
2026-11-16 2026-11-16 PlS Planned sale

Chief Medical Officer

Officer
1,000 -5.5%
101.53
US$100,000
1,000 -5.5% 101.53 US$100,000
2026-11-16 2026-11-16 PlS Planned sale

Chief Medical Officer

Officer
1,000 -4.1%
100.48
US$100,000
1,000 -4.1% 100.48 US$100,000
2026-11-16 2026-11-16 PlS Planned sale

Chief Medical Officer

Officer
1,000 -6.7%
99.52
US$100,000
1,000 -6.7% 99.52 US$100,000
2026-11-13 2026-11-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,000 -0.7%
107.00
US$100,000
1,000 -0.7% 107.00 US$100,000
2026-11-13 2026-11-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,000 -6.3%
106.18
US$100,000
1,000 -6.3% 106.18 US$100,000
2026-11-13 2026-11-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,000 -30.9%
105.28
US$100,000
1,000 -30.9% 105.28 US$100,000
2026-11-13 2026-11-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,000 -3.5%
104.25
US$100,000
1,000 -3.5% 104.25 US$100,000
2026-11-13 2026-11-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,000 -3.4%
103.16
US$100,000
1,000 -3.4% 103.16 US$100,000
2026-11-13 2026-11-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,000 -2.1%
101.98
US$100,000
1,000 -2.1% 101.98 US$100,000
2026-11-13 2026-11-12 PlS Planned sale Non-Executive Director
1,000 -100.0%
106.99
US$100,000
1,000 -100.0% 106.99 US$100,000
2026-11-13 2026-11-12 PlS Planned sale Non-Executive Director
1,000 -92.6%
106.05
US$100,000
1,000 -92.6% 106.05 US$100,000
2026-11-13 2026-11-12 PlS Planned sale Non-Executive Director
1,000 -79.9%
105.31
US$100,000
1,000 -79.9% 105.31 US$100,000
2026-11-13 2026-11-12 PlS Planned sale Non-Executive Director
1,000 -13.2%
104.16
US$100,000
1,000 -13.2% 104.16 US$100,000
2026-11-13 2026-11-12 PlS Planned sale Non-Executive Director
1,000 -7.7%
103.09
US$100,000
1,000 -7.7% 103.09 US$100,000
2026-11-13 2026-11-12 PlS Planned sale Non-Executive Director
1,000 -6.6%
102.10
US$100,000
1,000 -6.6% 102.10 US$100,000
2026-11-12 2026-11-12 PrS Proposed sale

Officer

Officer
1,000
107.17
US$100,000
1,000 107.17 US$100,000
2026-11-12 2026-11-12 PrS Proposed sale

Director

Non-Executive Director
1,000
107.17
US$100,000
1,000 107.17 US$100,000
2026-11-02 2026-11-02 PlS Planned sale

Chief Executive Officer

Executive Director
1,000 -0.0%
98.40
US$100,000
1,000 -0.0% 98.40 US$100,000
2026-11-02 2026-11-02 PlS Planned sale

Chief Executive Officer

Executive Director
1,000 -0.1%
97.45
US$100,000
1,000 -0.1% 97.45 US$100,000
2026-11-02 2026-11-02 PlS Planned sale

Chief Executive Officer

Executive Director
1,000 -0.3%
96.70
US$100,000
1,000 -0.3% 96.70 US$100,000
2026-11-02 2026-11-02 PlS Planned sale

Chief Executive Officer

Executive Director
1,000 -1.6%
95.64
US$100,000
1,000 -1.6% 95.64 US$100,000
2026-11-02 2026-11-02 PlS Planned sale

Chief Executive Officer

Executive Director
1,000 -0.7%
94.77
US$100,000
1,000 -0.7% 94.77 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale

Director; Officer

Executive Director
1,000
96.87
US$100,000
1,000 96.87 US$100,000
2026-10-20 2026-10-20 PlS Planned sale

General Counsel

Officer
3,000 -9.1%
79.49
US$238,474
3,000 -9.1% 79.49 US$238,474
2026-10-20 2026-10-20 PlS Planned sale

General Counsel

Officer
4,100 -11.1%
78.79
US$323,037
4,100 -11.1% 78.79 US$323,037
2026-10-20 2026-10-20 PlS Planned sale

General Counsel

Officer
1,000 -2.6%
77.21
US$77,205
1,000 -2.6% 77.21 US$77,205
2026-10-20 2026-10-20 PlS Planned sale

General Counsel

Officer
500 -1.3%
76.12
US$38,059
500 -1.3% 76.12 US$38,059
2026-10-20 2026-10-20 PlS Planned sale

General Counsel

Officer
400 -1.0%
74.90
US$29,960
400 -1.0% 74.90 US$29,960
2026-10-15 2026-10-15 PlS Planned sale

Chief Medical Officer

Officer
200 -0.6%
77.71
US$15,542
200 -0.6% 77.71 US$15,542
2026-10-15 2026-10-15 PlS Planned sale

Chief Medical Officer

Officer
700 -2.1%
76.67
US$53,666
700 -2.1% 76.67 US$53,666
2026-10-15 2026-10-15 PlS Planned sale

Chief Medical Officer

Officer
1,400 -4.1%
75.48
US$105,677
1,400 -4.1% 75.48 US$105,677
2026-10-15 2026-10-15 PlS Planned sale

Chief Medical Officer

Officer
1,847 -5.1%
74.69
US$137,957
1,847 -5.1% 74.69 US$137,957
2026-10-15 2026-10-15 PlS Planned sale

Chief Medical Officer

Officer
2,853 -7.4%
73.89
US$210,806
2,853 -7.4% 73.89 US$210,806
2026-10-15 2026-10-15 PrS Proposed sale

Officer

Officer
21,000
76.68
US$1,610,280
21,000 76.68 US$1,610,280
2026-10-13 2026-10-12 PlS Planned sale

Senior Vice President, Finance

Officer
200 -1.4%
82.84
US$16,567
200 -1.4% 82.84 US$16,567
2026-10-13 2026-10-12 PlS Planned sale

Senior Vice President, Finance

Officer
1,958 -12.0%
81.86
US$160,272
1,958 -12.0% 81.86 US$160,272
2026-10-13 2026-10-12 PlS Planned sale

Senior Vice President, Finance

Officer
2,100 -11.4%
80.76
US$169,596
2,100 -11.4% 80.76 US$169,596
2026-10-13 2026-10-12 PlS Planned sale

Senior Vice President, Finance

Officer
5,741 -23.7%
80.03
US$459,453
5,741 -23.7% 80.03 US$459,453
2026-10-13 2026-10-12 PrS Proposed sale

Officer

Officer
9,999
82.11
US$821,018
9,999 82.11 US$821,018
2026-10-02 2026-10-01 PlS Planned sale

Chief Executive Officer

Executive Director
200 -0.0%
84.78
US$16,956
200 -0.0% 84.78 US$16,956
2026-10-02 2026-10-01 PlS Planned sale

Chief Executive Officer

Executive Director
8,554 -0.9%
84.03
US$718,755
8,554 -0.9% 84.03 US$718,755
2026-10-02 2026-10-01 PlS Planned sale

Chief Executive Officer

Executive Director
16,246 -1.7%
83.40
US$1,354,882
16,246 -1.7% 83.40 US$1,354,882
2026-10-01 2026-10-01 PrS Proposed sale

Director; Officer

Executive Director
25,000
83.29
US$2,082,250
25,000 83.29 US$2,082,250
2026-09-21 2026-09-21 PlS Planned sale

Senior Vice President, Finance

Officer
533 -3.6%
95.75
US$51,035
533 -3.6% 95.75 US$51,035
2026-09-21 2026-09-21 PlS Planned sale

General Counsel

Officer
2,667 -8.2%
95.31
US$254,196
2,667 -8.2% 95.31 US$254,196
2026-09-21 2026-09-21 PlS Planned sale

General Counsel

Officer
601 -1.8%
94.44
US$56,760
601 -1.8% 94.44 US$56,760
2026-09-21 2026-09-21 PlS Planned sale

General Counsel

Officer
3,832 -10.3%
93.32
US$357,592
3,832 -10.3% 93.32 US$357,592
2026-09-21 2026-09-21 PlS Planned sale

General Counsel

Officer
2,900 -7.3%
92.37
US$267,870
2,900 -7.3% 92.37 US$267,870
2026-09-21 2026-09-21 PrS Proposed sale

Officer

Officer
533
94.96
US$50,614
533 94.96 US$50,614
2026-09-15 2026-09-15 S Sale

Chief Medical Officer

Officer
947 -2.9%
95.71
US$90,637
947 -2.9% 95.71 US$90,637
2026-09-15 2026-09-15 PlS Planned sale

Chief Medical Officer

Officer
100 -0.3%
94.22
US$9,422
100 -0.3% 94.22 US$9,422
2026-09-15 2026-09-15 PlS Planned sale

Chief Medical Officer

Officer
1,366 -4.0%
92.99
US$127,023
1,366 -4.0% 92.99 US$127,023
2026-09-15 2026-09-15 PlS Planned sale

Chief Medical Officer

Officer
3,150 -8.4%
92.03
US$289,890
3,150 -8.4% 92.03 US$289,890
2026-09-15 2026-09-15 PlS Planned sale

Chief Medical Officer

Officer
2,384 -6.0%
91.10
US$217,173
2,384 -6.0% 91.10 US$217,173
2026-09-15 2026-09-15 S Sale

Chief Executive Officer

Executive Director
2,452 -0.3%
95.71
US$234,681
2,452 -0.3% 95.71 US$234,681
2026-09-15 2026-09-15 S Sale

General Counsel

Officer
1,039 -3.3%
95.71
US$99,443
1,039 -3.3% 95.71 US$99,443
2026-09-15 2026-09-15 S Sale

Senior Vice President, Finance

Officer
560 -3.7%
95.71
US$53,598
560 -3.7% 95.71 US$53,598
2026-09-15 2026-09-15 S Sale

Chief Operating Officer

Officer
906 -0.4%
95.71
US$86,713
906 -0.4% 95.71 US$86,713
2026-09-15 2026-09-11 PlS Planned sale

Senior Vice President, Finance

Officer
200 -1.3%
94.02
US$18,803
200 -1.3% 94.02 US$18,803
2026-09-15 2026-09-11 PlS Planned sale

Senior Vice President, Finance

Officer
2,208 -12.5%
93.26
US$205,921
2,208 -12.5% 93.26 US$205,921
2026-09-15 2026-09-11 PlS Planned sale

Senior Vice President, Finance

Officer
4,051 -18.6%
92.41
US$374,367
4,051 -18.6% 92.41 US$374,367
2026-09-15 2026-09-11 PlS Planned sale

Senior Vice President, Finance

Officer
3,000 -12.1%
91.11
US$273,322
3,000 -12.1% 91.11 US$273,322
2026-09-01 2026-09-01 PlS Planned sale

Chief Executive Officer

Executive Director
4,800 -0.5%
92.44
US$443,691
4,800 -0.5% 92.44 US$443,691
2026-09-01 2026-09-01 PlS Planned sale

Chief Executive Officer

Executive Director
63,596 -6.4%
91.90
US$5,844,237
63,596 -6.4% 91.90 US$5,844,237
2026-09-01 2026-09-01 PlS Planned sale

Chief Executive Officer

Executive Director
6,604 -0.7%
90.79
US$599,556
6,604 -0.7% 90.79 US$599,556
2026-09-01 2026-09-01 PlS Planned sale

Chief Operating Officer

Officer
4,000 -1.7%
92.01
US$368,054
4,000 -1.7% 92.01 US$368,054
2026-09-01 2026-09-01 PlS Planned sale

Chief Operating Officer

Officer
1,000 -0.4%
91.05
US$91,048
1,000 -0.4% 91.05 US$91,048
2026-09-01 2026-09-01 PrS Proposed sale

Officer

Officer
5,000
92.62
US$463,100
5,000 92.62 US$463,100
2026-09-01 2026-09-01 PrS Proposed sale

Director; Officer

Executive Director
75,000
92.62
US$6,946,500
75,000 92.62 US$6,946,500
2026-08-17 2026-08-17 PlS Planned sale

Chief Medical Officer

Officer
2,480 -7.0%
112.56
US$279,154
2,480 -7.0% 112.56 US$279,154
2026-08-17 2026-08-17 PlS Planned sale

Chief Medical Officer

Officer
3,320 -8.6%
112.01
US$371,886
3,320 -8.6% 112.01 US$371,886
2026-08-17 2026-08-17 PlS Planned sale

Chief Medical Officer

Officer
300 -0.8%
110.52
US$33,155
300 -0.8% 110.52 US$33,155

See older Oruka Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Oruka Therapeutics Inc history with Plus

Billed monthly · Cancel anytime